Drugs / Qishen Yiqi dripping pills
Qishen Yiqi dripping pills
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT06006689 | Sep 2023 → Sep 2025 | diabetic kidney disease | Tasly Pharmaceutical Group Co., Ltd | Unknown | No outcome recorded |
| Phase 2 | NCT04944706 | Jul 2021 → Dec 2024 | diastolic heart failure | Tasly Pharmaceutical Group Co., Ltd | Completed | No outcome recorded |
| Phase 2 | NCT04983043 | Jun 2021 → Nov 2024 | symptomatic heart failure | Tasly Pharmaceutical Group Co., Ltd | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07687186 | Jun 2026 → Jun 2028 expected | heart failure | Tasly Pharmaceutical Group Co., Ltd | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06699407 | Nov 2024 → Dec 2026 expected | heart failure | Qilu Hospital of Shandong University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06699420 | Nov 2023 → Dec 2025 overdue | coronary microvascular disorder | Qilu Hospital of Shandong University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01555320 | Mar 2012 → Sep 2013 | heart failure | State Administration of Traditional Chinese Medicine of the People's Republic of China | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04471298 Comparator | Sep 2020 → Jan 2021 | — | Tasly Pharmaceutical Group Co., Ltd | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02875639 Comparator | Jun 2016 → Dec 2019 | heart failure | Zhu Mingjun | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qishen Yiqi dripping pills | “Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)” NCT06006689 ↗10“Qishen Yiqi dripping pills (QSYQ), a TCM drug, have been commonly used alongside standardized Western medicine to treat IHF.” PMID 23672353 ↗ May 2013 |
| Known as | Qishen Yiqi dropping pills | “PURPOSE: This study aimed to evaluate whether the effect of Qishen Yiqi dropping pills (QSYQ) on the clinical outcome of patients with chronic ischemic heart failure (IHF) is...” PMID 41268060 ↗ Nov 2025 |
| Known as | QSYQ | “Previous clinical studies have shown that Qishen Yiqi dropping pills (QSYQ) have the effect of treating chronic heart failure.” PMID 38169574 ↗ Dec 20231“Qishen Yiqi dripping pills (QSYQ), a TCM drug, have been commonly used alongside standardized Western medicine to treat IHF.” PMID 23672353 ↗ May 2013 |
| Modality | Traditional medicine (herbal / TCM) | “a TCM drug” PMID 23672353 ↗ May 2013 |
| Route | Oral | “Qishenyiqi dripping pills, 3.12g, oral, three times a day” NCT04471298 ↗ |